97 related articles for article (PubMed ID: 10189189)
1. Induction of interleukin-10 on activation of Epstein-Barr virus in EBV-infected B-cell lines.
Sairenji T; Ohnishi E; Inouye S; Kurata T
Viral Immunol; 1998; 11(4):221-31. PubMed ID: 10189189
[TBL] [Abstract][Full Text] [Related]
2. Effect of genistein, a tyrosine kinase inhibitor, on latent EBV activation induced by cross-linkage of membrane IgG in Akata B cells.
Daibata M; Mellinghoff I; Takagi S; Humphreys RE; Sairenji T
J Immunol; 1991 Jul; 147(1):292-7. PubMed ID: 1711079
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus (EBV) replication and expressions of EA-D (BMRF1 gene product), virus-specific deoxyribonuclease, and DNA polymerase in EBV-activated Akata cells.
Daibata M; Sairenji T
Virology; 1993 Oct; 196(2):900-4. PubMed ID: 8396819
[TBL] [Abstract][Full Text] [Related]
4. [The mechanisms of Epstein-Barr virus activation in B cells].
Sairenji T
Nihon Rinsho; 1997 Feb; 55(2):316-20. PubMed ID: 9046817
[TBL] [Abstract][Full Text] [Related]
5. Activation of latent EBV via anti-IgG-triggered, second messenger pathways in the Burkitt's lymphoma cell line Akata.
Daibata M; Humphreys RE; Takada K; Sairenji T
J Immunol; 1990 Jun; 144(12):4788-93. PubMed ID: 2161880
[TBL] [Abstract][Full Text] [Related]
6. Functional role of phosphatidylinositol 3-kinase/Akt pathway on cell growth and lytic cycle of Epstein-Barr virus in the Burkitt's lymphoma cell line, P3HR-1.
Mori T; Sairenji T
Virus Genes; 2006 Jun; 32(3):327-34. PubMed ID: 16732486
[TBL] [Abstract][Full Text] [Related]
7. Phosphatidylinositol 3-kinase is a determinant of responsiveness to B cell antigen receptor-mediated Epstein-Barr virus activation.
Iwakiri D; Takada K
J Immunol; 2004 Feb; 172(3):1561-6. PubMed ID: 14734735
[TBL] [Abstract][Full Text] [Related]
8. Human B-cell interleukin-10: B-cell lines derived from patients with acquired immunodeficiency syndrome and Burkitt's lymphoma constitutively secrete large quantities of interleukin-10.
Benjamin D; Knobloch TJ; Dayton MA
Blood; 1992 Sep; 80(5):1289-98. PubMed ID: 1325212
[TBL] [Abstract][Full Text] [Related]
9. Viral interleukin 10 is critical for the induction of B cell growth transformation by Epstein-Barr virus.
Miyazaki I; Cheung RK; Dosch HM
J Exp Med; 1993 Aug; 178(2):439-47. PubMed ID: 8393476
[TBL] [Abstract][Full Text] [Related]
10. Early events in Epstein-Barr virus genome expression after activation: regulation by second messengers of B cell activation.
Mellinghoff I; Daibata M; Humphreys RE; Mulder C; Takada K; Sairenji T
Virology; 1991 Dec; 185(2):922-8. PubMed ID: 1660209
[TBL] [Abstract][Full Text] [Related]
11. The vIL-10 gene of the Epstein-Barr virus (EBV) is conserved in a stable manner except for a few point mutations in various EBV isolates.
Kanai K; Satoh Y; Yamanaka H; Kawaguchi A; Horie K; Sugata K; Hoshikawa Y; Sata T; Sairenji T
Virus Genes; 2007 Dec; 35(3):563-9. PubMed ID: 17763933
[TBL] [Abstract][Full Text] [Related]
12. The interaction of mitogen-activated protein kinases to Epstein-Barr virus activation in Akata cells.
Satoh T; Hoshikawa Y; Satoh Y; Kurata T; Sairenji T
Virus Genes; 1999; 18(1):57-64. PubMed ID: 10334038
[TBL] [Abstract][Full Text] [Related]
13. Virus and cell RNAs expressed during Epstein-Barr virus replication.
Yuan J; Cahir-McFarland E; Zhao B; Kieff E
J Virol; 2006 Mar; 80(5):2548-65. PubMed ID: 16474161
[TBL] [Abstract][Full Text] [Related]
14. The interleukin-10 homolog encoded by Epstein-Barr virus enhances the reactivation of virus-specific cytotoxic T cell and HLA-unrestricted killer cell responses.
Stewart JP; Rooney CM
Virology; 1992 Dec; 191(2):773-82. PubMed ID: 1333123
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus-encoded poly(A)(-) RNA supports Burkitt's lymphoma growth through interleukin-10 induction.
Kitagawa N; Goto M; Kurozumi K; Maruo S; Fukayama M; Naoe T; Yasukawa M; Hino K; Suzuki T; Todo S; Takada K
EMBO J; 2000 Dec; 19(24):6742-50. PubMed ID: 11118209
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of cell growth and Epstein-Barr virus reactivation by CD40 stimulation in Epstein-Barr virus-transformed B cells.
Fukuda M; Satoh TA; Takanashi M; Hirai K; Ohnishi E; Sairenji T
Viral Immunol; 2000; 13(2):215-29. PubMed ID: 10893001
[TBL] [Abstract][Full Text] [Related]
17. Induction of Epstein-Barr virus (EBV) reactivation in Raji cells by doxorubicin and cisplatin.
Hsu CH; Hergenhahn M; Chuang SE; Yeh PY; Wu TC; Gao M; Cheng AL
Anticancer Res; 2002; 22(6C):4065-71. PubMed ID: 12553034
[TBL] [Abstract][Full Text] [Related]
18. hTERT inhibition triggers Epstein-Barr virus lytic cycle and apoptosis in immortalized and transformed B cells: a basis for new therapies.
Giunco S; Dolcetti R; Keppel S; Celeghin A; Indraccolo S; Dal Col J; Mastorci K; De Rossi A
Clin Cancer Res; 2013 Apr; 19(8):2036-47. PubMed ID: 23444223
[TBL] [Abstract][Full Text] [Related]
19. Accumulation of Epstein-Barr virus (EBV) BMRF1 protein EA-D during latent EBV activation of Burkitt's lymphoma cell line Raji.
Ohashi M; Horie K; Hoshikawa Y; Nagata K; Osaki M; Ito H; Sairenji T
Microbes Infect; 2007 Feb; 9(2):150-9. PubMed ID: 17223371
[TBL] [Abstract][Full Text] [Related]
20. A novel function for the Epstein-Barr virus transcription factor EB1/Zta: induction of transcription of the hIL-10 gene.
Mahot S; Sergeant A; Drouet E; Gruffat H
J Gen Virol; 2003 Apr; 84(Pt 4):965-974. PubMed ID: 12655098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
